These results demonstrate that NASH fEVs increase the Caco‐2 cell permeability, associated with a decrease in occludin and ZO‐1 protein expression, via a TLR4‐insensitive inhibitor pathway. The gene discussed is OCLN; the disease is metabolic dysfunction-associated steatohepatitis.